Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease

Published:2014-07-15 Issue:6 Volume:40 Page:620-628
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Mazor Y.¹²,Almog R.¹²,Kopylov U.³,Ben Hur D.¹,Blatt A.¹,Dahan A.¹,Waterman M.¹²,Ben-Horin S.³,Chowers Y.¹²

Affiliation:

1. Gastroenterology Department; Rambam Health Care Campus; Haifa Israel

2. Bruce Rappaport School of Medicine; Technion Israel Institute of Technology; Haifa Israel

3. Sheba Medical Center & Sackler School of Medicine; Tel-Aviv University; Ramat Gan Israel

Funder

'Talpiot' medical leadership grant

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12869/fullpdf

Reference30 articles.

1. The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis;Garces;Ann Rheum Dis,2012

2. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial;Sandborn;Ann Intern Med,2007

3. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

4. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis;Bartelds;Ann Rheum Dis,2007

5. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis;Radstake;Ann Rheum Dis,2009

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

2. Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study;Ocular Immunology and Inflammation;2024-04-23

3. Rescue therapy with upadacitinib in medically refractory pediatric ulcerative colitis;JPGN Reports;2024-04

4. Albumin change predicts failure in ulcerative colitis treated with adalimumab;PLOS ONE;2024-01-02

5. Therapeutic drug monitoring of immunotherapies with novel Affimer–NanoBiT sensor construct;Sensors & Diagnostics;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3